Announce Date | 05/05/2025 |
EPS Normalized Actual | $0.57 (Beat by $0.2) |
EPS GAAP Actual | $0.57 (Beat by $0.2) |
Revenue Actual | $2.389B |
Revenue Surprise | Beat by $2389M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $3.70085 |
EPS GAAP Estimate | $3.70085 |
Revenue Estimate | $3.002703409B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 11.95 | 5.07 | 11.01258 | 12.66464 | 1 |
Dec 2028 | 10.85 | 5.59 | 9.99887 | 11.49886 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.19 | -3.49038 | 2.389B | -9.29% | -502.79M |
FQ4 2024 (Dec 2024) | -17.5 | -17.5 | 2.37B | -8.4% | 2370M |
FQ3 2024 (Sep 2024) | 2.23 | 2.23 | 2.648B | -2.83% | 2648M |
FQ2 2024 (Jun 2024) | 1.42 | 1.42 | 2.651B | -5.43% | 2651M |
FQ1 2024 (Mar 2024) | 1.11 | 1.11 | 2.611B | -9.27% | 2611M |
FQ4 2023 (Dec 2023) | 6.37 | 6.37 | 2.569B | 8.6% | 2569M |
FQ3 2023 (Sep 2023) | 8.73 | 8.73 | 2.723B | 15.5% | 2723M |
FQ2 2023 (Jun 2023) | 2.02 | 2.02 | 2.795B | 11.06% | 2795M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
3.70085
Consensus Revenue Estimates
3.002703409B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 2.61 | -- | 2.34048 | 2.77473 | 1 |
FQ2 2027 (Jun 2027) | 2.58 | -- | 2.31358 | 2.74284 | 1 |
FQ1 2027 (Mar 2027) | 2.20789 | -- | 2.02045 | 2.35297 | 7 |
FQ4 2026 (Oct 2026) | 4.06825 | -- | 3.83827 | 4.44337 | 9 |
FQ3 2026 (Jul 2026) | 4.03368 | -- | 3.80565 | 4.40562 | 9 |
FQ2 2026 (Jun 2026) | 4.17038 | -- | 3.95393 | 4.45501 | 9 |
FQ1 2026 (Mar 2026) | 3.56633 | 105.33 | 3.56633 | 3.56633 | 10 |
FQ4 2025 (Oct 2025) | 3.783 | 562.6 | 3.56914 | 4.13182 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 2.78B | -- | 2.56B | 2.92B | 3 |
FQ2 2027 (Jun 2027) | 2.65B | -- | 2.44B | 2.78B | 3 |
FQ1 2027 (Mar 2027) | 2.41B | -- | 2.26B | 2.54B | 3 |
FQ4 2026 (Oct 2026) | 3.08B | -- | 2.95B | 3.3B | 5 |
FQ3 2026 (Jul 2026) | 3.22B | -- | 3.08B | 3.44B | 5 |
FQ2 2026 (Jun 2026) | 3.21B | -- | 3.08B | 3.38B | 5 |
FQ1 2026 (Mar 2026) | 3.01B | 20.66 | 3.01B | 3.01B | 6 |
FQ4 2025 (Oct 2025) | 2.98B | 20.55 | 2.85B | 3.19B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 3.30038 | -0.19 | -3.49038 | 1837.04% |
FQ4 2024 (Dec 2024) | -17.5 | -17.5 | 100% | |
FQ3 2024 (Sep 2024) | 2.23 | 2.23 | 100% | |
FQ2 2024 (Jun 2024) | 1.42 | 1.42 | 100% | |
FQ1 2024 (Mar 2024) | 1.11 | 1.11 | 100% | |
FQ4 2023 (Dec 2023) | 6.37 | 6.37 | 100% | |
FQ3 2023 (Sep 2023) | 8.73 | 8.73 | 100% | |
FQ2 2023 (Jun 2023) | 2.02 | 2.02 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $2.89B | $2.39B | $-502.79M | -21.05% |
FQ4 2024 (Dec 2024) | $0B | $2.37B | $2370M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.65B | $2648M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.65B | $2651M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.61B | $2611M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.57B | $2569M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.72B | $2723M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2.8B | $2795M | 100% |